Table 1. Incidence of Hypercalcemia by Tumor Typea
| Tumor Type | Incidence (%) of Hypercalcemia of Malignancy | |
| aAdapted from Kaplan.[1] | ||
| Breast (with bone metastases) | 30–40 | |
| Multiple myeloma | 20–40 | |
| Squamous cell carcinoma of lung | 12.5–35 | |
| Squamous cell carcinoma of head and neck | 2.9–25 | |
| Renal cell carcinoma | 3–17 | |
| Lymphomas | ||
| Hodgkin lymphoma | 0.6–5.4 | |
| Non-Hodgkin lymphoma, high-grade | 14–33 | |
| T-cell lymphoma (human T-cell, lymphotrophic virus type 1) | 50 | |
| Other malignancies: ovary, liver, pancreas, esophagus, cervix | 7 | |
| Unknown primary | 7 | |
References
- Kaplan M: Hypercalcemia of malignancy. In: Yarbro CH, Wujcik D, Gobel BH, eds.: Cancer Nursing: Principles and Practice. 7th ed. Sudbury, Mass: Jones and Bartlett Publishers, 2010, pp 939-63.
